Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

ENMD-2076

Home/Tag:ENMD-2076
14 11, 2010

Experimental Ovarian Cancer Drug, ENMD-2076, May Work Against Acute Myeloid Leukemia & Multiple Myeloma Too!

Tags: , , , , |0 Comments

Here is another pre-ASH press release from PRNewswire.com:ENMD-2076 Phase 1 Data in Hematological Studies to be Presented at ASHENMD-2076 Multiple Myeloma and Leukemia Abstracts to be Published in BloodROCKVILLE, Md., Nov. 9, 2010 /PRNewswire-FirstCall:EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2

15 07, 2010

New British Anti-Myeloma Drug Study Shows Promise

Tags: , |0 Comments

Here is a link to a British study abstract about another new, anti-myeloma drug:EntreMed’s ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models.The study results were published in the British Journal of Haematology.ENMD-2076 is another variation of a kinase inhibitor.  Lots of research going on worldwide using kinase inhibitors against multiple myeloma.  Hopefully some